G9090 Onc diagnosis rectal t1-2 no progr
Also known as: rectal cancer T1-T2, early rectal cancer, rectal cancer no progression
Oncology diagnosis for rectal cancer stages T1-T2 without distant metastasis and no disease progression.
In Plain Language
early stage rectal cancer; small rectal tumors; rectal cancer without spread
Clinical Context
Quality reporting code for patients with early-stage rectal cancer with good prognosis and no evidence of recurrence.
RVU Information
CPT G9090 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9090?
CPT G9090 (Onc diagnosis rectal t1-2 no progr) is a G Codes code. Oncology diagnosis for rectal cancer stages T1-T2 without distant metastasis and no disease progression.
Who uses CPT code G9090?
CPT G9090 is used by Colorectal Surgery, Medical Oncology, Radiation Oncology. Quality reporting code for patients with early-stage rectal cancer with good prognosis and no evidence of recurrence.
When is CPT G9090 used?
Quality reporting code for patients with early-stage rectal cancer with good prognosis and no evidence of recurrence.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.